Association of the Neutrophil/Lymphocyte Ratio With Clinical Complications and Mortality in COVID-19 Patients

NCT ID: NCT04434157

Last Updated: 2020-06-16

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 221 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2020-03-28
• Study Completion Date: 2020-05-05

Brief Summary

There is little information about the clinical characteristics and risk factors of Covid-19 in Latin American countries considering the ethnic differences and the high prevalence of obesity and cardiometabolic diseases. The aim of the study was to evaluate the association between laboratory tests and the risk of complications in SARS-CoV-2 infection and to determine their mortality risk factors in a sample of the Mexican population.

A retrospective cross-sectional study of the routinely collected data was performed in the Hospital Regional de Alta Especialidad de Ixtapaluca (HRAEI), State of Mexico. Adult patients (aged ≥18 years) with positive RT-PCR for SARS-CoV-2 and oxygen support that were admitted between March 28 and May 5, 2020, were included

Detailed Description

Data collection Data was collected deidentified admission from adult patients, with oxygen therapy. Data were extracted from clinical medical records and the electronic database of daily laboratory test results. Also, incomplete clinical records were included. The number of cases in the area during the study period determined the sample size, no formal hypotheses being implemented. All patients who met the inclusion criteria were included.

Study variables Demographic variables (sex and age), chronic medical histories (hypertension, diabetes and cancer), laboratory plasma, and serum-based biomarkers, as well as the mortality, mechanical ventilation, and length of stay, were considered. Leukocytosis was considered as a leucocyte count above 10 x 103/mcL, a cut point of INL> 10, d- dimer 500 U/L, DHL> 500U/L, low count of lymphocytes < 0·5103/mcL as risk factors exposure to death and mechanical ventilation.

A new variable was create combining the data of neutrophil count (ANC) and lymphocyte count (ALC) to obtain the neutrophil-to-lymphocyte ratio (NLR) (calculated dividing the ANC by the ALC).

Outcomes The hypothesis was formulated before the statistical analysis. Our primary outcomes were to 1) To describe the clinical characteristics of the Mexican population with SARS-CoV-2 infection, and 2) To determine the mortality risk factors in Covid-19.

Secondary outcomes included 1) To identify the chronic diseases related to Covid-19 in Mexican population and 2) To evaluate the differences in hematic and biochemical parameters between survivors and no survivors.

Conditions

Covid-19

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: CROSS_SECTIONAL

Eligibility Criteria

Inclusion Criteria

1. Adult patients (aged ≥18 years)

2. Clinical (Positive RT-PCR for SARS-CoV-2 test) and radiological diagnosis of pulmonary infection by COVID-19

3. Diagnosis of acute respiratory distress syndrome clinical panel in accordance with Berlin 2012 criteria

4. Need of non-invasive ventilation (NIV or CPAP) or invasive ventilation (intubation)

Exclusion Criteria

1. Previous diagnosis of severe liver or kidney failure.

2. Patients with Human Immunodeficiency Virus (HIV) infection.

3. Patients with previous hematological diseases (Leukemia) that condition alterations in blood counts.

4. Consumption of treatments with any type of immunosuppressants prior to admission that conditions low lymphocytes.

5. Patients with a diagnosis of active or non-active cancer.

6. Absence of a clinical record for monitoring the data.

7. Pregnancy.

8. Patients referred from other institutions for their medical care. Clinical records of patients who requested their voluntary discharge Clinical records that do not include information of the course of COVID-19 infection

• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Hospital General de México Dr. Eduardo Liceaga

OTHER_GOV

Sponsor Role: collaborator

Hospital Regional de Alta especialidad de Ixtapaluca

OTHER

Sponsor Role: lead

Responsible Party

Omar Ramos-Peñafiel

Christian Ramos Peñafiel, MD, PhD

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Hospital Regional de Alta Especialidad de Ixtapaluca

Ixtapaluca, State of Mexico, Mexico

Countries

Mexico

Other Identifiers

NR-09-2020

Identifier Type: -

Identifier Source: org_study_id